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ABSTRACT We have examined the effects of a number of derivatives of ryanodine on K+ conduction in the Ca2+ release
channel purified from sheep cardiac sarcoplasmic reticulum (SR). In a fashion comparable to that of ryanodine, the addition
of nanomolar to micromolar quantities to the cytoplasmic face (the exact amount depending on the derivative) causes the
channel to enter a state of reduced conductance that has a high open probability. However, the amplitude of that reduced
conductance state varies between the different derivatives. In symmetrical 210 mM K+, ryanodine leads to a conductance
state with an amplitude of 56.8 ± 0.5% of control, ryanodol leads to a level of 69.4 ± 0.6%, ester A ryanodine modifies to
one of 61.5 ± 1.4%, 9,21-dehydroryanodine to one of 58.3 + 0.3%, 93,21 -epoxyryanodine to one of 56.8 ± 0.8%,
9-hydroxy-21 -azidoryanodine to one of 56.3 ± 0.4%, 1 0-pyrroleryanodol to one of 52.2 ± 1.0%, 3-epiryanodine to one of
42.9 ± 0.7%, CBZ glycyl ryanodine to one of 29.4 ± 1.0%, 21 -p-nitrobenzoyl-amino-9-hydroxyryanodine to one of 26.1
0.5%, ,B-alanyl ryanodine to one of 14.3 ± 0.5%, and guanidino-propionyl ryanodine to one of 5.8 ± 0.1% (chord
conductance at +60 mV, ± SEM). For the majority of the derivatives the effect is irreversible within the lifetime of a
single-channel experiment (up to 1 h). However, for four of the derivatives, typified by ryanodol, the effect is reversible, with
dwell times in the substate lasting tens of seconds to minutes. The effect caused by ryanodol is dependent on transmembrane
voltage, with modification more likely to occur and lasting longer at +60 than at -60 mV holding potential. The addition of
concentrations of ryanodol insufficient to cause modification does not lead to an increase in single-channel open probability,
such as has been reported for ryanodine. At concentrations of .500 juM, ryanodine after initial rapid modification of the
channel leads to irreversible closure, generally within a minute. In contrast, comparable concentrations of f-alanyl ryanodine
do not cause such a phenomenon after modification, even after prolonged periods of recording (>5 min). The implications of
these results for the site(s) of interaction with the channel protein and mechanism of the action of ryanodine are discussed.
Changes in the structure of ryanodine can lead to specific changes in the electrophysiological consequences of the
interaction of the alkaloid with the sheep cardiac SR Ca2+ release channel.
INTRODUCTION
The identification of ryanodine as a specific ligand for the
sarcoplasmic reticulum (SR) Ca2+ release channel has ad-
vanced significantly the fields of excitation-contraction cou-
pling in both skeletal and cardiac muscle; ryanodine is often
used in electrophysiological settings to specifically isolate
or block the SR. Much information about the function of
this intracellular network has been gained from such studies
(Marban and Wier, 1985; Beuckelmann and Wier, 1988;
Bers and Bridge, 1989; DuBell et al., 1993; Negretti et al.,
1993). These observations are paralleled by observations
from SR vesicle studies in which ryanodine leads to an
increase in Ca2+ efflux at nanomolar to low micromolar
concentrations, whereas in high ,uM to mM quantities it
leads to an inhibition. The availability of a tritiated form of
ryanodine has led to detailed binding studies being per-
formed on SR membranes. These experiments have sup-
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ported the existence of one, two, or more binding sites
(Pessah and Zimanyi, 1991; Wang et al., 1993). In addition,
[3H]ryanodine has allowed us and others to carry out bio-
chemical purification of the Ca2' release channel (Wil-
liams, 1992).
It has now been well established that when either native
SR membranes, under the appropriate ionic conditions, or
the purified ryanodine receptor is reconstituted into planar
phospholipid bilayers, under voltage-clamp conditions, a
cation-selective ligand-regulated channel of high conduc-
tance can be observed. The channel displays many of the
properties expected of the Ca2+ release protein (Williams,
1992; Meissner, 1994). The interaction of ryanodine at the
single-channel level in concentrations above 50 nM is char-
acterized most strikingly by a highly specific effect, namely
the irreversible production of a reduced conductance state of
high open probability (Rousseau et al., 1987). Furthermore,
concentrations of ryanodine in the 10-50 nM range have
also been observed to increase single-channel open proba-
bility without modification of conductance, and in the 100
,uM to 2 mM concentration range ryanodine has been re-
ported to lead to irreversible channel closure (Lai et al.,
1989; Buck et al., 1992).
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The structural features of some ryanodine derivatives are
shown in Scheme 1. Ryanodine (1) is isolated from the
stems of Ryania speciosa Vahl and consists principally of
two active constituents, ryanodine (1) and 9,21-dehydrory-
anodine (not shown). Recently, a series of derivatives of
ryanodine have been synthesized. Competition binding as-
says with [3H]ryanodine indicate that some interact with the
channel with higher affinity than ryanodine, whereas others
are of much lower affinity (Humerickhouse et al., 1993;
Gerzon et al., 1993). The experimental behavior of these
derivatives has been examined in binding assays and in
experiments in which 45Ca2+ efflux from SR vesicles has
been determined. However, the effect of these derivatives
has not been characterized at the single-channel level. In
this paper we present an overview of the electrophysiolog-
ical effects of a series of selected ryanodine derivatives on
the purified Ca2+ release channel of sheep cardiac muscle
SR reconstituted into planar phospholipid bilayers.
MATERIALS AND METHODS
Materials
Phosphatidylethanolamine was purchased from Avanti Polar Lipids (Bir-
mingham, AL), and phosphatidylcholine was from Sigma (Poole, Dorset,
England). [3H]Ryanodine was obtained from New England Nuclear (Bos-
ton, MA). Aqueous counting scintillant was purchased from Packard
(Groningen, The Netherlands). Other chemicals were obtained as the best
available grade from BDH (Dagenham, Essex, England), Aldrich Chemical
Company (Gillingham, Dorset, England), or Sigma.
Synthesis of the ryanodine derivatives
The compounds studied in this communication are loosely termed ryano-
dine derivatives; in strict chemical terms this is not correct for all those
studied. Ryanoids or ryanodine congeners are naturally occurring com-
pounds isolated from the Ryania speciosa Vahl bark and include ryanodine
(1), dehydroryanodine (not shown), and ester A ryanodine (8). The 010.q-
ryanodine esters, including CBZ glycyl ryanodine (4), (3-alanyl ryanodine
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(5), and guanidino-propionyl ryanodine (6), are true derivatives, as they are
obtained by derivatization of ryanodine, retain some biological activity of
the parent aLkaloid, and can regenerate the parent alkaloid by chemical or
enzymatic means. Ryanodol (2) is a degradation product in which the
pyrrole carboxylic acid fragment is lost. The others are probably best
considered as modification products in which the skeleton structure has
been altered-changes which under physiological conditions cannot be
altered. However, despite these chemical considerations, for ease of refer-
ence we refer to them all as derivatives. The methods of synthesis are as
given previously (Humerickhouse et al., 1993; Gerzon et al., 1993).
Small aliquots of the derivatives were added to the cytoplasmic face of
the channel from concentrated stock solutions. A shorthand terminology is
adopted in the ensuing discussion: ester A ryanodine (8) is referred to as
ester A, CBZ glycyl ryanodine (4) as CBZ glycyl, 21-p-nitrobenzoyl-
amino-9-hydroxyryanodine (not shown) as 21-p-nitro, ,3-alanyl ryanodine
(5) as (3-alanyl, guanidino-propionyl ryanodine (6) as guanidino-propionyl,
9,21-dehydroryanodine (not shown) as 9,21 dehydro, 93,21(3-epoxyryano-
dine (not shown) as epoxyryanodine, 9-hydroxy-21-azidoryanodine (not
shown) as azidoryanodine, 10-pyrroleryanodol (3) as 10-pyrrole, and
3-epiryanodine (7) as 3-epi.
Preparation of sheep cardiac heavy sarcoplasmic
reticulum membrane vesicles
Sheep hearts were collected from a farm (Selborne Biological) in ice-cold
cardioplegic solution (Tomlins et al., 1986). Junctional or heavy sarcoplas-
mic reticulum membrane (HSR) vesicles were isolated from the interven-
tricular septum and left ventricular free wall as previously described
(Sitsapesan and Williams, 1990). Differential centrifugation of the muscle
homogenate provides a mixed membrane fraction, which when fractionated
further on a discontinuous sucrose gradient yields a HSR fraction at its
30/40% (w/v) interface. The HSR fraction was resuspended in 0.4 M KCI
before sedimentation at 36,000 rpm (100,000 X gev) for 1 h in a Sorvall
A641 rotor. The resulting pellet was resuspended in a solution containing
0.4 M sucrose, 5 mM HEPES, titrated to pH 7.2 with Tris (hydroxymeth-
yl)-methylamine (Tris) and then snap-frozen in liquid nitrogen for storage
overnight at -80°C.
Solubilization and separation of the
ryanodine receptor
The solubilization of the ryanodine receptor by the zwitterionic detergent
3-[(3-cholamidopropyl)-dimethylammonio]-1-propane sulphonate, subse-
quent separation, and reconstitution into proteoliposomes were performed
as described previously (Lindsay and Williams, 1991).
Planar lipid bilayer methods
Lipid bilayers, formed from suspensions of phosphatidylethanolamine in
n-decane (35 mg/ml), were painted across a 200-,um-diameter hole in a
polystyrene copolymer partition that separated two chambers, referred to as
the cis (volume 0.5 ml) and trans (volume 1.5 ml) chambers. The trans
chamber was held at virtual ground, while the cis chamber could be
clamped at various holding potentials relative to ground. Current flow
across the bilayer was measured with an operational amplifier as a current-
voltage converter as described by Miller (1982). Bilayers were formed in
solutions of 200 mM KCI, 20 mM HEPES, titrated with KOH to pH 7.4,
resulting in a solution containing 210 mM K.-An osmotic gradient was
established by the addition of a small quantity (usually 50 to 100 ,ul) of 3
M KCI to the cis chamber. Proteoliposomes were added to the cis chamber
and stirred. To induce fusion of the vesicles with the bilayer, a second
small aliquot (50 to 100 ,ul) of 3 M KCI was added to the cis chamber.
After channel incorporation, further fusion was prevented by perfusion of
the cis chamber with 210 mM K+. Solutions contained 10 ,uM free Ca21
(8-12 ,uM as measured using an Orion Ca2+-selective electrode) as con-
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taminant, which was generally sufficient for channel activation. Occasion-
ally it was necessary to raise the Ca2+ in the cis chamber to 50-100 ,LM
to obtain sufficient activation. Experiments were carried out at room
temperature (21 ± 2°C).
The receptor channel incorporates in a fixed orientation in the bilayer;
the cis chamber corresponds to the cytosolic face of the channel and the
trans to the luminal (Lindsay and Williams, 1991; Tinker et al., 1992a). In
the subsequent discussion this naming convention will be adopted, and
current flowing from the cytoplasm to the interior of the SR will be referred
to as positive to ground.
Single-channel data acquisition
Single-channel current fluctuations were displayed on an oscilloscope and
stored on videotape. For analysis, data were replayed, filtered with an
8-pole Bessel filter, and digitized on an AT based computer system (Satori;
Intracel, Cambridge, England). Data were filtered at 1 kHz and digitized at
4 kHz. Single-channel current amplitudes and single-channel open proba-
bility were determined from digitized data.
The ryanodine derivatives produce substates of varying amplitude in
symmetrical 210 mM K+. With some derivatives the amplitude of the
substate was small, closures from this level were rare, and sometimes these
occurred at levels of conductance intermediate between the substate and
closed conductance. The combination of these factors meant that current-
voltage relationships were difficult to determine for all of the derivatives.
As a result, the change in single-channel current amplitude between the
modified and unmodified channels was determined at the point of modi-
fication at a holding potential of +60 mV (effectively the ratio of the chord
conductances). The result was expressed as a ratio (the fractional conduc-
tance in percentage terms) of the currents before and after modification.
We have adopted this method previously in our work on ryanodine mod-
ification of channel function (Lindsay et al., 1994). Channel open proba-
bility was determined by using 50% threshold criteria (Colquhoun and
Sigworth, 1983). Single-channel P. was obtained from at least 150 s of
continuous recording. In those experiments with ryanodol where a simple
comparison of dwell times was necessary, the data were played out on a
very slow time base on a pen recorder. The relevant dwell times were
compared by direct measurement with a ruler.
The representative traces shown in the figures were obtained from
digitized data acquired with Satori V3.2 transferred as an HPGL graphics
file to a graphics software package (CorelDraw; Corel Systems Corpora-
tion, Ottawa, Canada) for annotation and printing.
RESULTS
The derivatives lead to modification
The most striking action of ryanodine at the single-channel
level is a profound modification of gating and conduction
such that after a variable period of exposure of the cytosolic
face of the channel to concentrations greater than 100 nM,
the channel suddenly enters a state of reduced conductance
that has a high open probability. Do the ryanodine deriva-
tives cause a similar effect? The addition of these deriva-
tives to the cytosolic face of the receptor channel also leads
to the production of a substate with very high open proba-
bility (Fig. 1). However, one striking difference is that the
amplitude of the current of the reduced conductance state is
different for each of the derivatives. We have quantified this
information in terms of the fractional conductance (see
Materials and Methods), and the data are summarized in
Table 1. It can be seen from Fig. 1 that closures from the
modified state are rare, and this is even more pronounced at
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FIGURE 1 Representative single-channel traces at a holding potential of
60 mV in symmetrical 210 mM K+, showing the various values of
fractional conductance occurring upon modification by the various deriv-
atives. The records were filtered at 1 kHz and digitized at 4 kHz. The
control trace is shown in A, modification by 40 ,uM ryanodol in B, by 2 ,M
ester A in C, by 500 nM 9,21-dehydroryanodine in D, by 200 nM ryano-
dine in E, by 5 ,uM CBZ ryanodine in F, by 500 nM 21-p-nitro ryanodine
in G, by 500 p,M l3-alanyl ryanodine in H, and by 100 nM guanidino
propionyl ryanodine in I. The point of modification is marked with an
arrow below the trace. A second unmodified channel is present in record C,
and occasional openings of this channel can be seen on top of the modified
channel. The dotted lines indicate the levels of the closed (C), modified
(M), and open (0) states.
negative holding potentials. Transitions do occasionally oc-
cur to states of conductance intermediate between the mod-
ified and the closed conductance levels, with all of the
derivatives as with ryanodine (not shown). At the concen-
trations indicated in Table 1, modification generally oc-
curred within 5 min of addition.
On two occasions the 21-p-nitro derivative caused mod-
ification to levels (approximately 13% and 50%) other than
that indicated in Table 1. It is possible that these events
occurred as the result of the interaction of other ryanodine
derivatives, present at low concentrations as impurities
generated during the synthesis of this derivative, with the
channel.
Little difference was seen in the current amplitudes after
modification at -60 and +60 mV for all but one of the
derivatives. For example, fractional conductances deter-
mined at -60 mV for ryanodol were 67.9 ± 0.5% (±SEM
n = 8), a value not much different from that in Table 1.
There was one exception to this trend. In the case of the
guanidino propionyl derivative, currents at -60 mV were
obviously larger, and a figure of 12.1 ± 1.2% (+SD, n = 3)
was obtained for fractional conductance at this holding
potential.
Some derivatives are reversible
In Table 1 we classify the derivatives as either reversible or
irreversible. The majority of these compounds behave in a
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TABLE I Fractional conductance resulting immediately after
modification with the series of ryanodine derivatives
Fractional Effective
Derivative conductance N concentration Reversibility
Ryanodine 56.8 + 0.5% 12 .100 nM Irreversible
9,21- 58.3 ± 0.3% 6 .500 nM Irreversible
Dehydro
Ryanodol 69.4 ± 0.6% 12 220 ,uM Reversible
Ester A 61.5 ± 1.4% 8 1 ,uM Irreversible
9f3,21,3- 56.8 + 0.8% 4 .8 ,uM Irreversible
Epoxy
9-Hydroxy- 56.3 ± 0.4% 9 .10 ,uM Reversible
21 -azido
10-Pyrrole 52.2 ± 1.0% 7 .4 ,LM Mixed
3-Epi 42.9 ± 0.7% 8 .8 ,uM Reversible
CBZ-glycyl 29.4 ± 1.0% 6 .2 ,iM Irreversible
21-p-Nitro 26.1 ± 0.5% 11 .500 nM Irreversible
/3-Alanyl 14.3 ± 0.5% 5 .50 nM Irreversible
Guanidino- 5.8 ± 0.1% 11 .40 nM Irreversible
propionyl
The fractional conductance is the ratio of the chord conductance at +60
mV before and after modification. The statistics are calculated as + SEM,
where N refers to the number of measured modifications. The effective
concentration is the concentration that led, in most cases, to modification
within 5 min. It does not exclude the possibility that modification could
occur at lower concentrations. The implications of the terms "reversible/
irreversible" and "mixed" are indicated in the text.
fashion comparable to that of ryanodine in that the modifi-
cation is essentially irreversible within the lifetime of the
experiment. Perfusion of the derivative from the cytosolic
face of the channel leaves this property unaltered. However,
four of the compounds tested led to modification that spon-
taneously reversed during recording. These compounds,
generally with lower binding affinities (ryanodol, azido,
10-pyrrole, and 3-epi; Welch et al., manuscript submitted
3-epiryanodine
+60 mV -60 mV
C~ ~~~~~--
I 0-pyrroleryanodol
+60 mV
-60 mVi 111 :1'1l!T -----1i---
M--l ----------- C j
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120 pA
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FIGURE 2 Representative single-channel traces at holding potentials as
indicated on the figure in symmetrical 210 mM K+. The records were
filtered at 1 kHz and digitized at 4 kHz. The diagram shows modification
at the positive holding potentials (marked by the solid arrow) and its
reversal at the negative holding potential (marked by the dashed arrow) by
8 ,uM 3-epiryanodine and by 4 ,uM 10 pyrrole ryanodol. The dotted lines
indicate the levels of the closed (C), modified (M), and open (0) states.
for publication), led to modification that was spontaneously
reversible in the continued presence of the derivative. Fig. 2
illustrates modification at positive holding potentials and its
reversal at negative holding potentials with 10-pyrrole and
3-epi as examples. Fig. 3 A shows an example of sponta-
neous modification with ryanodol at +60 mV (indicated by
arrow 1 in the diagram) and reversal of that modification
(indicated by arrow 2 in the diagram).
Dwell times in the modified state varied for the reversible
derivatives. For 10-pyrrole, 3-epi, and azido dwell times
were very long at +60 mV holding potential, with reversal
of modification occurring only occasionally over a 3-min
recording period. For ryanodol, dwell times were shorter,
generally lasting tens of seconds to minutes at a holding
potential of +60 mV. Perfusion of the reversible derivative
from the cytoplasmic face of the channel led to channel
behavior identical to that of control. A simple interpretation
of these phenomena is that the binding and unbinding of the
reversible derivatives correspond to "modification" and "re-
versal of modification" observed at the single-channel level.
The probability of these derivatives causing modification
seemed to be quite steeply concentration dependent. For
example, with ryanodol, during 5-min observation periods,
modification never occurred at 10 ,uM at a +60 mV holding
potential, only occasionally with 20 ,uM, but frequently at
40 ,iM. It was apparent with all of the reversible derivatives
that modification was more likely to occur and lasted longer
at positive as compared to negative holding potentials.
Dwell times were much shorter at negative holding poten-
tials for these derivatives, with reversal of modification
generally occurring within a minute.
In addition, the 10-pyrrole derivative showed a further
property. After a variable period of time (-10 min) the
effect would become irreversible. In other words, the mod-
ification would not reverse even holding for over 5 min at
-60 mV, and the modified state would be present for the
lifetime of the experiment after perfusion of l0-pyrrole
ryanodine from the cytoplasmic face of the channel. This
tended to occur more quickly as higher concentrations were
used.
Voltage dependence of modification
As outlined above, the likelihood of modification and the
length of dwell time in the modified state were dependent
on holding potential with all the reversible derivatives. It
was also apparent with the irreversible basic derivatives
(f3-alanyl and guanidino propionyl) that modification oc-
curred more quickly at +60 mV and only occasionally and
at higher concentrations at -60 mV holding potential.
This interesting behavior was investigated further with
the reversible derivative ryanodol. Although the length of
the dwell times made it very difficult to obtain quantitative
estimates of the voltage dependence, the reversibility of the
ryanodol effect made it possible to make a qualitative sta-
tistical demonstration of the effect. Two types of experiment
Tinker et al. 2113
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FIGURE 3 The effects of ryanodol. (A) All traces re-
corded in symmetrical 210 mM K+ at 60 mV holding
potential filtered at 1 kHz and digitized at 4 kHz. (Upper
trace) Control trace in the absence of ryanodol. (Middle
trace) Onset of modification in the presence of 20 ,uM
(marked by arrow 1). Lower trace) Point of reversal of
modification (marked by arrow 2). (B) A continuous pe-
riod of 40 s of recording showing the interaction of 40 ,uM
ryanodol with the receptor channel at holding potentials as
illustrated in the diagram in symmetrical 210 mM K+. The
trace was filtered at 500 Hz and digitized at 2 kHz. The
protocol shown is that adopted for the qualitative exami-
nation of the voltage dependence of ryanodol dwell times.
The dotted lines indicate the levels of the closed (C),
modified (M), and open (0) states. At +60 mV channel
openings are indicated by an upward deflection; at -60
mV channel openings are indicated by a downward deflec-
tion of the trace. An unmodified channel is held at +60
mV before the onset of modification (marked by arrow 1).
There follows a dwell period in the modified state before
the spontaneous reversal of modification (marked by ar-
row 2). The period between arrows 1 and 2 is equivalent to
tl. A second modification occurs (marked by arrow 3), and
the holding potential is switched to -60 mV (marked by
arrow 4; capacitance spike reduced in size for display). At
the point marked by arrow 5, the modification once again
reverses. The period t2 + t3 is equivalent to the length of
time between arrows 3 and 5. In this piece of the trace it
can be seen that t, > t2 + t3. The holding potential is once
again switched to +60 mV (marked by arrow 6; capaci-
tance spike reduced in size for display). Modification once
again occurs at +60 mV (marked by arrow 7).
t
20 pA
Is
were performed with 40 ,M ryanodol at ± 60 mV holding
potential.
In the first series of experiments an attempt was made to
demonstrate the qualitative dependence of the on rate of
ryanodol on holding potential. The channel was held at +60
mV and the "trial" series begun at the end of the first
modification. After this event, holding potential was held at
+60 mV for 30 s and at the end of this period was switched
to a holding potential of -60 mV for 30 s. If the channel
modified at +60 but not -60 mV, this was scored as 1; if
it modified at -60 but not +60 mV, this was scored as -1;
and no score was awarded if modification occurred at both
potentials or did not occur at either. Quite commonly the
channel rapidly modified and did not "unmodify" at +60
mV during the 30-s period. In these circumstances switch-
ing to a negative holding potential led to "unmodification"
M -----I-F* _;
20 pA
B
Holding potential (.mV.)
60 _ _ _
MC)
C
M
0
t t
2 11 .4
t t
6
within approximately 10 s, and the 30-s recording period
was begun at this moment. If modification was equally
likely to occur at both the positive and negative membrane
potentials, then the net score was zero, with an equal num-
ber of "modifications at +60 but not at -60 mV" as
"modifications at -60 but not at +60 mV." In fact, in
experiments performed with the above protocol, the score
was +48, with no trials having the result of "modification at
-60 but not +60 mV" (results obtained from n = 4 bilay-
ers; full results in Table 2). If the results "modification at
+60 but not at -60" and "modification at -60 but not at
+60 mV" were equally likely, then the probability of ob-
taining this result by chance would be (0.5)48. More for-
mally, it is possible to estimate confidence intervals for the
binomial distribution using Student's t-distribution and
given that the variance is np(l- p) (where n is the number
t
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TABLE 2 Dependence of the on rate of ryanodol on holding
potential
Trial No. of such results
Modification at +60 but not -60 mV 48
Modification at -60 but not +60 mV 0
Modification at both +60 and -60 mV 3
No modification at either potential 10
of trials and p is the probability of the event occurrence)
(Clarke and Cooke, 1983). The null hypothesis that modi-
fication is equally likely to occur at +60 as at -60 mV (p
= 0.5) holding potential is rejected at the 0.1% level (one-
and two-tailed). In fact, the null hypothesis is near rejection,
with p 0.9 at the 1% level (in other words modification is
nine times more likely to occur at +60 mV). By use of the
Boltzmann relationship it is possible to estimate that the
valency of the on reaction must be at least on the order of
0.6-0.7. This voltage dependence of the ryanodol modifi-
cation was independent of Po, as activation with sulmazole
analogs (McGarry and Williams, 1994) did not affect the
observation, and voltage dependence was independent of
whether ryanodol was bound or unbound at the point of
switching to a negative holding potential.
Experiments similar in principle were used to determine
whether the off rate for ryanodol was voltage dependent,
i.e., if once modified, were the channel dwell times in the
modified state dependent on holding potential? The follow-
ing protocol was used. A channel was held at +60 mV and
the dwell time in a modification at +60 mV (tl) was
obtained. The holding potential was held at +60 mV until a
second modification occurred and then switched to -60
mV. The time spent at +60 mV was added to the time spent
at -60 mV until "unmodification" (t2 + t3) occurred. An
example of one such trial is shown in Fig. 3 B; tl, t2, and t3
are further explained in the legend. If dwell times are
independent of voltage, then there ought to be as many trials
with tl > t2 + t3 as there are with t1 < t2 + t3. The results
from a series of four bilayers are given in Table 3.
The results lead to the rejection of the null hypothesis (at
the 0.2% level using a two tailed Student's t-test) that
ryanodol dwell times are unaffected by holding potential
and suggest that, as is the case with the on rate, the off rate
of ryanodol is dependent on voltage.
Other comparisons with ryanodine
In addition to the modification reaction described above,
two other unrelated effects have been suggested to occur
with ryanodine. At low concentrations (10-50 nM) an in-
TABLE 3 Dependence of the off rate of ryanodol on holding
potential
Trial No. of such results
ti > t2 + t3 25
t I < t2 + t3 6
crease in single-channel P0 has been noted to occur (Bull et
al., 1989; Buck et al., 1992). We have examined one deriv-
ative to see whether it causes a similar phenomenon. The
ryanodol derivative was used at concentrations of 10-20
,M, where modification occurs rarely, to see whether sin-
gle-channel P. increases with this derivative. In symmetri-
cal 210 mM K+ with contaminant Ca2+ (-10 ,uM) at the
cytoplasmic face of the channel, there was no convincing
increase in single-channel P0 at ±60 mV holding potential.
The results are shown in Table 4. Whether this pattern
extends to all of the other derivatives remains to be estab-
lished, but it does imply that derivatives need not necessar-
ily possess this additional property.
The second effect of ryanodine has been less well docu-
mented at the single-channel level. We have noted previ-
ously that there is a tendency for modified channels to close
irreversibly during long experiments with continued expo-
sure of the cytosolic face of the channel to micromolar
quantities of ryanodine. This tendency can be overcome by
the removal of ryanodine from the cytosolic face of the
channel after modification.
Channel closure is more readily observed at higher con-
centrations of ryanodine. In our hands, when .500 ,uM
ryanodine is added to the cytoplasmic face of the channel,
an initial rapid modification of all channels to the substate
occurs, subsequently followed by closure, i.e., cessation of
channel activity, within 1 min (n = 7). However, in a
similar series of experiments in which we used 100 ,uM
ryanodine and followed channel activity for 3 min, only one
channel closed during this period. The subsequent elevation
of the concentration of ryanodine to 1 mM led to rapid
closure of all channels within 1 min (n = 9). The effect is
irreversible, as perfusion of the ryanodine from the cytosolic
face of the channel after closure does not lead to a return of
single-channel activity. The effect is illustrated in Fig. 4 A.
Measurement of bilayer capacitance indicated that channel
activity was not lost as the result of a ryanodine-induced,
nonspecific thickening of the bilayer.
As with ryanodine, comparable concentrations (1 mM) of
the basic derivative 3-alanyl cause rapid modification; how-
ever, with this derivative there is no subsequent closure of
the modified channel up to 3-5 min later. In a series of five
bilayers (with n = 14 channels) only one channel closed in
this period. The subsequent addition of 1 mM ryanodine to
the ,3-alanyl modified channel also failed to produce chan-
nel closure. This was the case under conditions where the
,B-alanyl ryanodine was either maintained or perfused from
the cytosolic face of the channel. This effect is illustrated in
Fig. 4 B.
TABLE 4 Influence of low concentrations of ryanodol on
open probability
Concentration P. at +60 mV (±SD) P. at -60 mV (±SD)
Control 0.015 ± 0.006 (n = 4) 0.003 ± 0.001 (n = 4)
10 ,uM ryanodol 0.009 ± 0.007 (n = 3) 0.004 ± 0.003 (n = 3)
20,u.M ryanodol 0.012+ 0.005 (n = 4) 0.003 + 0.004 (n = 4)
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FIGURE 4 All traces recorded in symmetrical 210 mM K+ at a holding potential of 60 mV. The records were filtered at 1 kHz and digitized at 4 kHz.
Closed (C) and modified (M) levels are indicated by the dotted lines on the diagrams. (A) (Upper trace) Modified channel in the presence of 100 ,uM
ryanodine. (Middle trace) Closure within 1 min after elevation of the concentration of ryanodine to 1 mM at the cytoplasmic face of the channel. In this
particular record there is a very brief excursion to a higher conducting state before closure. This was seen occasionally in other experiments, but closure
was by no means invariably accompanied by this phenomenon. (Lower trace) After perfusion of ryanodine from the cytoplasmic face, showing that this
does not reverse the closure. (B) The upper trace shows a modified channel in the presence of 1 mM ,B-alanyl ryanodine at the cytoplasmic face of the
channel, the middle trace shows the channel after perfusion of the ryanodine derivative away, and the lower trace shows the channel after the addition of
1 mM ryanodine at the cytoplasmic face. It is to be noted from the traces that the modified channel closes more frequently in the presence of 1 mM (3-alanyl
ryanodine. This was seen in all other experiments. It may represent a form of block by the positively charged derivative. It was not investigated further.
DISCUSSION
Modification induced by ryanodine and
its derivatives
It seems most likely that the observation of modification
with ryanodine and the derivatives corresponds to interac-
tion with the high-affinity binding site observed in binding
studies. Initially this may seem at odds with the observation
of a slow on rate in binding studies and the variable time to
modification observed at the single-channel level. However,
the overall binding affinity is determined by both the un-
binding and the binding rate constants. In the case of ryan-
odine the unbinding rate as determined from binding studies
is very slow, and the ryanodine modification of channel
gating and conduction is essentially irreversible, certainly
within the lifetime of a single-channel experiment. Thus the
combination of a slow binding rate constant but a much
slower unbinding rate constant leads overall to a high af-
finity. Why is the binding rate constant so slow? If it were
determined simply by diffusion it would be much faster
(107-109 M-1 s-1). This observation implies a more com-
plex ligand-receptor interaction. Previous work from our
laboratory (Williams and Holmberg, 1990) suggests that
ryanodine binds to the open channel, and perhaps it is even
necessary that the channel enters a specific open conforma-
tion before the binding site is sufficiently exposed. It has
been suggested that interaction of ryanodine with the high-
affinity binding site in fact corresponds, at the single-chan-
nel level, to the increase in PO observed with low nanomolar
concentrations of ryanodine (Bull et al., 1989; Buck et al.,
1992). However, even this effect required several minutes
before onset and was readily reversible with perfusion,
suggesting a relatively fast unbinding rate (Buck et al.,
1992).
The reversibility of modification seen with, for example,
ryanodol and the relatively lower affinity of these com-
pounds compared to ryanodine also support the contention
that a major determinant of the binding equilibrium is the
unbinding rate from the modified state. It has been proposed
(Welch et al., 1994) that one component of importance in
the binding of ryanodine is stabilized by a hydrophobic
interaction at the 3 substituted position. The shorter dwell
times of the more polar ryanodol and 10-pyrrole ryanodol
support this proposition. However, the two other reversible
derivatives identified here, 3-epi and 9-hydroxy-21-azido
ryanodines, have a pyrrole substitution at the 3 position
identical to that of ryanodine. Clearly, other chemical alter-
ations in the ryanodine structure can have a significant
A
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effect on the off rate. Dwell times for all of the reversible
derivatives studied so far were too long to obtain sufficient
quantitative information for kinetic studies. We have previ-
ously used such studies to reveal kinetic information con-
cerning the interaction of QX314 and the large tetraalkyl
ammonium cations with the sheep cardiac Ca2+ release
channel conduction pathway (Tinker et al., 1992b; Tinker
and Williams, 1993). Such approaches can be quite power-
ful in revealing quantitative detail of molecule-channel in-
teraction. The synthesis of a derivative with even lower
affinity may open up these possibilities.
The observation that for 10-pyrrole ryanodol, reversible
modification can progress to an irreversible state is intrigu-
ing and open to a number of interpretations. It could suggest
sequential positively cooperative binding of at least two
derivatives, i.e., with one bound the off rate is relatively
fast, whereas with two the off rate becomes much slower
and the effect becomes irreversible. Alternatively, there
may be two conformations of a single 10-pyrrole in the
binding site, one with a fast and the other with a slow off
rate.
The nature of the conductance change induced
by ryanodine and its derivatives
One of the most intriguing observations made with the
derivatives is that the fractional conductance of the modi-
fied level in 210 mM K+ shows a wide spectrum of values
from approximately 70% for ryanodol to nearly 5% for
guanidino propionyl. What does this say about the mecha-
nism of substate production and how ryanodine derivative
structure influences the resulting fractional conductance?
There are two broad hypotheses. The first supposes that the
change is induced by direct interaction within the conduc-
tion pathway, in other words a form of partial block in
which the ryanoid interacts with a site within the conduction
pathway and reduces, but does not completely prevent,
single-channel current flow. The increased open probability
is caused by the occupation of the site, making it much more
difficult for the open channel to close. This is the explana-
tion we have used to account for a number of other substate
phenomena in the sheep cardiac Ca2' release channel
(Tinker and Williams, 1993). The alternative thesis envis-
ages ryanodine binding at a site distant from the conduction
pathway but inducing a conformational change that results
in a stabilized open state with reduced conductance, i.e., an
allosteric hypothesis. How does the available evidence
weigh in favor of each of these possibilities?
The multitude of different fractional conductances seen
with the derivatives and the rectification seen with gua-
nidino propionyl but not the other derivatives would seem
easier to rationalize in terms of partial block. Derivatives
bind to and unbind from the same site located within the
conduction pathway, and the nature of the interacting spe-
cies determines the conductance change because of local
losteric hypothesis could be formulated along the lines of
the Monod-Wyman-Changeux (MWC) concerted mecha-
nism as used by enzyme kineticists. K+ is considered as the
substrate and conductance as the enzymatic rate, and the
channel consists of two conducting states. Ryanodine when
bound would favor the ryanodine-modified over the unmod-
ified conducting state (equivalent to the "tense" and "re-
laxed" states in the MWC mechanism). Interacting species
at the binding site are considered as stabilizing one or the
other of the states, reflecting the all-or-none nature of the
MWC mechanism. The problem then with including all of
the derivatives in such a scheme is that one would have to
suppose a series of different quaternary protein structures,
each corresponding to a unique conductance state and each
uniquely stabilized by a particular derivative. Although it is
impossible to exclude this situation, it is not especially
appealing. Also, we have demonstrated that the binding and
unbinding of ryanodol are influenced by membrane poten-
tial. For charged blocking or substate-inducing molecules
this is generally taken as adequate, although by no means
watertight evidence (Moczydlowski et al., 1984) for direct
entry into the conduction pathway. Ryanodol carries no net
charge, although it does have a fixed dipole. If the positively
charged part of the dipole had to lie in the voltage drop for
interaction, while the negative pole lay outside, the effect
would show an overall voltage dependence. Alternatively,
the ryanodine-binding site could be influenced by trans-
membrane potential such that binding is more likely to
occur at positive holding potentials. The most telling evi-
dence in favor of a partial block hypothesis would be the
demonstration of permeant ion competition with the inter-
acting species. Even ryanodol has dwell times an order of
magnitude too large to quantify this effect, but it may be
possible in the future to synthesize a derivative with much
shorter dwell times as we obtain more information on the
relationship between derivative structure and function.
Previously we performed a detailed analysis of the con-
duction properties of the ryanodine-modified state and com-
pared these with those of the unmodified SR Ca2' release
channel (Lindsay et al., 1994). The conclusion of these
studies is that ryanodine produces a profound, diffuse
change in many aspects of ion handling such that it is
impossible to propose one simple change to account for the
changes in fractional conductance seen with different ions.
This is highly suggestive of a widespread conformational
change and supports an allosteric hypothesis. It seems that
both hypotheses have their weaknesses.
One way of resolving these conflicting ideas is to suppose
that perhaps both hypotheses are correct-in other words,
that ryanodine derivatives bind in a vestibule-like region of
the conduction pathway. This has direct physical conse-
quences in terms of ion translocation, for example, by
affecting the electrostatics of permeant ion to channel in-
teraction or by simply reducing the capture radius for ion
entry, and leads to changes in ion handling at sites distant
from the binding site through a long-range conformational
effects within the conduction pathway. The alternative al-
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change. This reasoning is perhaps not so far-fetched. Zn21
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has been observed to induce a substate in the cardiac batra-
chotoxin-modified sodium channel. For the Zn2+ effect in
the cardiac batrachotoxin-modified sodium channel, kinetic
arguments support an allosteric hypothesis, whereas evi-
dence from site-directed mutagenesis in the putative vesti-
bule of the pore supports a binding site location at this point
(Schild et al., 1993; Schild and Moczydlowski, 1994). Fur-
thermore, there is some preliminary evidence that the ryan-
odine binding site lies within the pore-forming transmem-
brane regions of the SR Ca2+ release channel protein
(Callaway et al., 1994; Witcher et al., 1994).
Ryanodine causes specific inhibition of
single-channel activity
Ca2+ efflux from SR vesicles is enhanced by ryanodine in
concentrations from 100 nM to 100 ,uM. Increases of ryan-
odine concentration above this lead to a rapid decline in
efflux. However, the basic derivative ,B-alanyl ryanodine
does not show such behavior, and Ca2+ efflux plateaus at its
maximum value above concentrations of 100 ,uM (Humer-
ickhouse et al., 1993). The observations in this paper sug-
gest an explanation for this finding. Ryanodine, at concen-
trations comparable to those used in flux experiments to
reduce Ca2+ efflux, is able to produce a rapid, irreversible
inhibition of single-channel activity, a property not shared
by 13-alanyl ryanodine. Interestingly, the addition of milli-
molar quantities of ryanodine to a channel modified in the
presence of ,3-alanyl ryanodine does not lead to inhibition.
One possible explanation for this interesting finding is that
the ability to presumably bind a further ryanodine to close
the channel is contingent upon the channel already having
been modified with ryanodine.
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